Le Lézard
Classified in: Health, Science and technology
Subject: CALENDAR OF EVENTS

DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call


MINNEAPOLIS, March 18, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its 2018 financial results will be released after market close on Tuesday, March 19th.  DiaMedica's management will host a live conference call on Wednesday, March 20th at 8:00am Central Time to provide a business update and discuss the Company's financial results.

Conference Call details:

Date:March 20, 2019
Time:8:00 AM CT
Web access:https://edge.media-server.com/m6/p/idbwv4bq
Dial In:(866) 962-3593 (domestic)
 (630) 652-5857 (international)
Conference ID:6773627

Listeners should log on to the website or dial in 15 minutes prior to the call.  The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until March 28, 2019, by dialing 1(855) 859-2056 (US Toll Free Dial In), (404) 537-3406 (international), replay passcode 6773627.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."

For more information, please visit www.diamedica.com.

Contact:

Scott Kellen
Chief Financial Officer
Phone: (763) 496-5118
[email protected]

Paul Papi
Vice President of Business Development
Phone: (617) 899-5941
[email protected]


These press releases may also interest you

at 13:34
California Yoga Therapist Expands Offerings in Effort to Make Mental Health Care More Accessible
Therapist Cara Behan LMFT, launches Yoga & Meditation Membership in effort to address growing mental health crisis and need for accessible care in communities across California. A Licensed Marriage and Family Therapist, certified yoga teacher, and...

at 13:30
New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement
A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis. The...

at 13:00
National Institutes of Health All of Us Research Program Mobile Tour Visits Columbus, Ohio
Starting next week, the Network of National Library of Medicine and Columbus Metropolitan Library in Columbus, OH will host the All of Us Journey. This traveling educational exhibit brings the National Institutes of Health's All of Us Research...

at 13:00
Avive Solutions Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest Emergency Response in Communities Nationwide
$56.5M Equity Financing Led by Questa Capital, Laerdal Million Lives Fund, and Catalyst Health Ventures, with New Participation from RC Capital and Eckuity CapitalAvive has rapidly built an expansive and diverse customer base, delivering its FDA...

at 13:00
MyProstateScore 2.0 Clinically Validated in New JAMA Oncology Study
Lynx Dx, a leader in innovative diagnostic solutions, hailed new peer-reviewed research published today in the Journal of the American Medical Association (JAMA) Oncology that validates the efficacy of MyProstateScore 2.0 (MPS2), the company's...

at 12:50
Kalderos Files Amicus Brief in Arkansas Contract Pharmacy Litigation
Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition...

More news about Health...


News published on and distributed by: